Profil
Lawrence Mertz currently works at Accelerate Diagnostics, Inc., as Chief Technology Officer from 2022.
Dr. Mertz also formerly worked at Biora Therapeutics, Inc., as Vice President-Research & Development, Engineering and Meridian Bioscience, Inc., as SVP-Clinical Operations, Research & Development from 2018 to 2021.
Dr. Mertz received his undergraduate degree and doctorate degree from State University of New York at Buffalo.
Aktive Positionen von Lawrence Mertz
| Unternehmen | Position | Beginn |
|---|---|---|
| ACCELERATE DIAGNOSTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.05.2021 |
Ehemalige bekannte Positionen von Lawrence Mertz
| Unternehmen | Position | Ende |
|---|---|---|
| MERIDIAN BIOSCIENCE, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.04.2021 |
| BIORA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Lawrence Mertz
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Meridian Bioscience, Inc.
Meridian Bioscience, Inc. Medical SpecialtiesHealth Technology Operates as a life science company that develops, manufactures, markets and distributes diagnostic products | Health Technology |
Accelerate Diagnostics, Inc.
Accelerate Diagnostics, Inc. Medical SpecialtiesHealth Technology Develops vitro diagnostics solutions | Health Technology |
State University of New York at Buffalo
State University of New York at Buffalo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biora Therapeutics, Inc.
Biora Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on developing targeted therapies for cancer and autoimmune diseases | Health Technology |
















